Xcout Intel
Tune Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Tune Therapeutics among biotechnology companies — ranked by similarity to what Tune Therapeutics actually does, not by market-cap band.
Subscribe to see Tune Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Tune Therapeutics
Tune Therapeutics, Inc. is a biotechnology company founded in 2020 that develops advanced genomic and epigenetic therapies, including epigenetic silencers.
Tune Therapeutics at a glance
Tune Therapeutics is a biotechnology company headquartered in United States. It has raised at least $357.4M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round, Series B, raised $175M in January 2025. Xcout tracks 13 named people at Tune Therapeutics, including John McHutchison (CEO, Chairman of the Board).
Tune Therapeutics leadership
- John McHutchisonCEO, Chairman of the Board
- Derek JantzChief Scientific Officer
- Heidi ZhangChief Development Officer
- Akira MatsunoCo-Founder, President, CFO, COO
- Charles GersbachCo-Founder
- Dan McHughCo-Founder, Investor
7 more named people on record for Tune Therapeutics, with roles, board committees and tenure — see the full roster →
Tune Therapeutics funding rounds
At least $357.4M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $175M | 4 named | |
| SEC Form D filing | $182.4M | — | |
| — | Undisclosed | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Tune Therapeutics competitors
Ranked by semantic similarity — how close each company is to Tune Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Exsilio Therapeutics Inc. is a biotechnology company headquartered in Boston, Massachusetts, founded in 2022 to pioneer genomic medicines and advanced genetic therapies.
Similar biotechnology company
Skylark Bio is a biotechnology company developing precision-targeted, locally delivered gene therapies to treat genetic hearing loss and other single-gene disorders. The company's platform aims to restore natural biological processes and hearing function, addressing conditions that affect children and individuals with genetic communication impairments.
Similar biotechnology company
Epicrispr Biotechnologies is a pioneering therapeutics company dedicated to developing advanced genetic medicines. The organization focuses on scientific research, platforms, and clinical pipelines to treat serious diseases.
Biotech
Azalea Therapeutics is a biotechnology company headquartered in Berkeley, California. The company focuses on precision genome engineering directly inside the body with an initial emphasis on developing in vivo cancer immunotherapies.
Similar biotechnology company
Base Therapeutics is a biotechnology company that develops next-generation gene editing technologies, including its proprietary AccuBase base editing system and enhanced prime editing technology. The company focuses on creating therapeutic solutions for cancer and genetic diseases, alongside engineered immune cell therapies such as BASE-NK and CAR-T products. It serves patients and partners with pharmaceutical and agricultural enterprises by licensing its precision gene editing tools.
Similar biotechnology company
KiraGen Bio is a Boston-based biotechnology company pioneering the development of AI-driven, multiplex gene-edited CAR-T cell therapies designed to target and block tumor suppression.
Biotech
Tessera Therapeutics is a biotechnology company developing programmable genetic medicines using its Gene Writing technology, which is based on mobile genetic elements to insert, replace, or modify DNA in cells. It aims to develop treatments for genetic diseases and other serious conditions, serving patients who need durable genetic therapies.
Biotech
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Similar biotechnology company
Shape Therapeutics, Inc. is a biotechnology research company founded in 2018 and headquartered in Seattle, Washington. The firm focuses on advancing the future of medicine through programmable RNA technologies and therapeutics.
Similar biotechnology company
Arbor Biotechnologies, Inc. is a next-generation gene editing company focused on discovering and developing precise genetic medicines for rare and complex diseases.
Biotech
Addition Therapeutics is a biotechnology research company based in South San Francisco, California. The firm is on a mission to fulfill the promise of genomic medicine for chronic and rare diseases, having emerged from stealth with significant funding.
Similar biotechnology company
GeneTether, Inc., also known as Rize Oncology, is a biotechnology company headquartered in San Lorenzo, California, focused on developing proprietary gene-editing technologies and targeted oncology therapeutics.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Tune Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Tune Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →